Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From F8-Modified iPSCs
Hemophilia A (HA), an X-linked recessive congenital bleeding disorder, affects 80%–85% of patients with hemophilia. Nearly half of severe cases of hemophilia are caused by a 0.6-Mb genomic inversion (Inv22) that disrupts F8. Although viral-based gene therapy has shown therapeutic effects for hemophi...
Main Authors: | Liyan Qiu, Mi Xie, Miaojin Zhou, Xionghao Liu, Zhiqing Hu, Lingqian Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.630353/full |
Similar Items
-
Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature
by: Lucas-Sebastian Spitzhorn, et al.
Published: (2019-03-01) -
CRISPR-Mediated In Situ Introduction or Integration of <i>F9-Padua</i> in Human iPSCs for Gene Therapy of Hemophilia B
by: Qiyu Tang, et al.
Published: (2023-05-01) -
Low-Intensity Pulsed Ultrasound Promotes Osteogenic Potential of iPSC-Derived MSCs but Fails to Simplify the iPSC-EB-MSC Differentiation Process
by: Ziyi Hua, et al.
Published: (2022-05-01) -
Targeted gene correction and functional recovery in achondroplasia patient-derived iPSCs
by: Huan Zou, et al.
Published: (2021-08-01) -
ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
by: Zhiqing Hu, et al.
Published: (2019-09-01)